ERBB2 and breast carcinoma: Small-molecule PTP1B inhibitors have been shown to block proliferation and induce cell death in HER2-positive and Herceptin-resistant breast cancer (9) but the question of what PTP1B substrates and networks are involved in this inhibitory effect remains unresolved.